A few weeks ago, I met the head of private equity of one of the largest pension funds in Asia and the world. A very impressive guy with terrific insight of the market, our conversation was great (from my standpoint) until I invited him to attend (and possibly speak in) some of our events. He said that there was little value for him to see most of the fund managers speaking on stage as they were already in his portfolio and he was familiar with their views. He also expressed concerns about being chased by GPs from other firms looking for allocations.
I can relate to his point of view to a certain extent. Over the years, I've seen many notable speakers, from both the LP and GP sides, mobbed by other managers, investors, service providers and press as...
Bertelsmann India Investments has earmarked USD 500m, provided by its eponymous German parent, for investment in local start-ups. The VC unit’s total deployment since its launch in 2013 is USD 285m.
UK-headquartered incubator Entrepreneur First (EF) has raised USD 158m, targeted in part at investment in Southeast Asian start-ups and expanding its reach in the region.
CDH Investments has agreed to sell New Zealand-based supplements manufacturer The Better Health Company (TBHC) to Nestlé Health Science for an undisclosed sum.
India and Southeast Asia-focused Panthera Growth Partners has reached a first close on its second fund with commitments amounting to more than half the overall target of USD 250m.